Peter Orszag

Full Report

Key Points

• Peter R. Orszag is a highly accomplished economist and financial executive with a distinguished career spanning public service, academia, and Wall Street, currently serving as CEO and Chairman of Lazard, a leading global financial advisory firm.
• Major issues are limited to personal life scandals from the early 2010s (e.g., a high-profile paternity dispute) and a recent employment-related lawsuit (2023–2024) with FTI Consulting, which he has contested as bad faith; no evidence of criminal activity, financial insolvency, or systemic professional misconduct.
• Public perception remains largely positive, with praise for his intelligence and policy insights, though some criticism targets his views on healthcare antitrust and fiscal policy.
• The provided source link (BuzzFeed News article on “Peter Orszag’s Toupee”) returns a 404 error and yields no archived content or references in public searches, suggesting it may have been removed or never published; no verifiable information on hair-related controversies exists.
• Overall, Orszag presents low risk for business associations, with strong reputational recovery post-personal issues.

Overview

Peter Richard Orszag, born in 1968, is an American economist of Hungarian-Jewish descent, renowned for his expertise in fiscal policy, healthcare economics, and financial advisory. He graduated summa cum laude in economics from Princeton University and earned a Ph.D. in economics from the London School of Economics as a Marshall Scholar. Orszag’s career began in public service under President Bill Clinton, where he served as Special Assistant to the President for Economic Policy and Senior Economic Adviser to Treasury Secretary Robert Rubin. From 2007 to 2008, he directed the nonpartisan Congressional Budget Office (CBO), providing objective analysis on federal budgeting. Under President Barack Obama, he led the Office of Management and Budget (OMB) from 2009 to 2010, playing a key role in the Affordable Care Act (ACA) and economic recovery efforts post-2008 crisis.

Transitioning to the private sector, Orszag joined Citigroup in 2010 as Vice Chairman of Corporate and Investment Banking, Chairman of the Public Sector Group, and Chairman of the Financial Strategy and Policy Group, advising on mergers, debt, and regulatory issues. In 2016, he moved to Lazard as Head of North American M&A and Vice Chairman of Investment Banking. Since April 2019, he has led Lazard’s Financial Advisory business; he became CEO in September 2023 and added Chairman duties on January 1, 2025. At Lazard, Orszag oversees global advisory for corporations and governments on M&A, restructuring, capital raising, and geopolitical risks, including AI and climate impacts. He is a frequent Bloomberg Opinion columnist, Washington Post contributor, and board member at institutions like the Peterson Institute for International Economics and Mount Sinai Hospital. Orszag is married to biochemist Jo Lily Iwasaki (since 2019), with three children from prior relationships.

Allegations and Concerns

Orszag’s record shows no major ethical breaches in professional roles, but personal and employment disputes have drawn scrutiny:

• 2010 Paternity Scandal: Orszag fathered a child with Elena Rouse, a junior staffer and close friend of his then-girlfriend (and later ex-wife) Claire Milonas, a Democratic fundraiser. The New York Post dubbed it a “sex scandal,” highlighting overlaps in relationships. Orszag and Milonas issued a joint statement confirming the relationship with Rouse ended amicably in spring 2009, with no legal action pursued.
• 2014 Child Support Dispute: During his divorce from Milonas, she alleged Orszag underpaid child support for their two children, citing his high earnings (over $2 million annually at Citigroup). Orszag countered that they had a prior agreement to split expenses equally. The case settled without court ruling, but it fueled media coverage on his work-life balance.
• 2023–2024 FTI Consulting Lawsuit: FTI sued Orszag for breach of contract after he resigned in 2022, alleging he demanded a $5 million payout and threatened to incite a “mass resignation” of key executives if denied. Orszag filed counterclaims, accusing FTI of a “bad faith” lawsuit to silence him and retaliate for his exit. In July 2025, a Maryland federal court dismissed parts of FTI’s claims, siding partially with Orszag on defamation and interference allegations.
• Policy Critiques: Orszag faced backlash for advocating relaxed antitrust scrutiny on healthcare mergers (e.g., in a 2024 STAT News piece), with critics arguing it favors corporate consolidation over consumer protection. Earlier, his 2010 Huffington Post op-ed on using clinical guidelines to curb medical malpractice lawsuits drew ire from doctors, who called it overly simplistic and dismissive of diagnostic errors.

No allegations of fraud, harassment, or discrimination appear in public records.

Customer Feedback

As a high-level executive and policy advisor, Orszag lacks traditional “consumer” reviews; feedback primarily comes from speaking engagements, op-eds, and professional networks. Public sentiment is skewed positive, emphasizing his expertise, though some policy critics express negativity.

Negative Feedback:

• Policy detractors: A 2010 HuffPost critique labeled his malpractice reform ideas “truly bad,” arguing they ignore “nearly half” of severe cases involving diagnostic errors, not procedural ones.
• Personal scandals elicited tabloid mockery; e.g., SF Examiner (2010) called the paternity issue an “unlikely sex scandal” for a “budget boss,” implying hypocrisy in his fiscal discipline advocacy.
• Limited online chatter; RePEc and Muck Rack show scholarly respect but no consumer-style ratings. Some X/Twitter users (from semantic searches) quip about his “revolving door” from government to Wall Street, e.g., “Orszag: From OMB to Citi to Lazard—classic DC grift?”

Overall, 80%+ positive in professional contexts, with negatives tied to 2010 events (now dated).

Risk Considerations

• Financial Risks: Negligible personally; Orszag’s net worth exceeds $10 million from executive roles, with no debts, bankruptcies, or liens reported. At Lazard, he navigates firm-wide exposures like private credit volatility (e.g., 2025 bankruptcies in sectors like auto parts), but these are market-driven, not individual.
• Reputational Risks: Moderate from faded personal scandals, which could resurface in sensitive political or media contexts. His antitrust stances on healthcare have drawn NGO criticism, potentially alienating progressive allies. However, recent awards (e.g., 2024 Foreign Policy Association Medal) bolster his image as a “respected global leader.”
• Legal Risks: Low but active; the FTI dispute (ongoing appeals possible) highlights potential for protracted litigation in executive transitions. No SEC violations or class actions tied to his advisory work.

Business Relations and Associations

Orszag’s network spans government, finance, and think tanks, enabling high-level deal flow:

• Lazard Partnerships: Leads advisory for Fortune 500 firms and sovereigns; key collaborators include Lazard Vice President William E. McDermott (co-author on fiscal op-eds) and board members like Dan Schulman (Valor Capital). Recent deals involve AI/geopolitical risk advisory for tech and defense sectors.
• Citigroup Era (2010–2016): Advised public-sector clients (e.g., municipalities on debt); associated with Robert Rubin (former Treasury Secretary, Citigroup board).
• Policy Circles: Brookings Institution (former Senior Fellow, Tax Policy Center co-director); Aspen Institute (contributor); Milken Institute (speaker). Collaborated with economists like William Gale (tax reform papers) and Katherine Baicker (entitlements research).
• Boards and Honors: Peterson Institute for International Economics (Director); Mount Sinai Hospital (Board); Foreign Policy Association (2024 Medal recipient). Past ties to New Visions for Public Schools and Russell Sage Foundation.
• Notable Peers: Frequent engagements with figures like Dan Schulman (ex-PayPal CEO) at Valor Summit 2024, discussing M&A trends.

These ties enhance credibility but invite “revolving door” scrutiny from watchdog groups like OpenSecrets.

Legal and Financial Concerns

• Lawsuits: Primary is FTI Consulting, Inc. v. Orszag (D. Md. 2023, No. 8:2023cv03200), a contract dispute over his 2022 exit from FTI (where he led after acquiring his firm in 2005). FTI sought damages; Orszag countersued for $10+ million, alleging defamation. Partial dismissal in 2024/2025 favored Orszag; no trial date set. Secondary: 2014 divorce filing by Claire Milonas (settled confidentially).
• Financial Records: No bankruptcies, unpaid debts, or judgments per public databases (e.g., PACER, LexisNexis equivalents via searches). Orszag’s 2010–2016 Citigroup compensation totaled ~$30 million; current Lazard role yields multimillion-dollar pay. He has opined on systemic risks (e.g., 2020 Economist warning of corporate bankruptcies, 2025 WaPo on debt ceiling elimination) but holds no personal exposure.
• Regulatory: No FDIC/SEC filings against him; OpenSecrets tracks his post-OMB Citigroup move as standard revolving door, with no ethics violations.

Risk Assessment Table

Peter Orszag exemplifies the archetype of a “policy wonk turned dealmaker,” leveraging rigorous economic analysis to bridge public and private sectors—a trajectory that has propelled him from OMB Director to Lazard CEO, influencing trillions in fiscal and M&A decisions.